Multi bagger coming. They have all the Covid testing and telehealth connections (with Mercer VIP) as CDBT but add in a 10 cancer blood test coming out by end of Q1.  Grail and Thrive were just bought out for billions and szls has a market cap of $40 million.  It could be a 10 bagger in no time.

Don't take my word for it do yourself a favor and check on the presentation from yesterday.  This board is for sharing information.  Don't say you weren't given this opportunity.

https://investorintel.com/markets/biotech-healthcare/biotech-news/stagezero-life-sciences-to-present-at-the-snn-network-canada-virtual-event-on-thursday-january-7-2021/


LithLover wrote:SZLS - stagezero life sciences already has a saliva test and in Canada they use Ichor and are the go to test for travelers for China, Hawaii and Barbados.  In addition they are just days/weeks away from their Q1 launch of a ARISTOTLE blood biopsy test.  10 cancers detected from a single blood test.  And a lower market cap than here and just completed a $7 million offering.  SZLS is Covid And cancer testing and already has telehealth set up with Mercer VIP.  Everything CBDT has and more for less market cap and more growth with 2 institutional investors already in calling for a $5.00 SP sitting at 0.70.  You're welcome.